NASDAQ: RANI - Rani Therapeutics Holdings, Inc.

半年間の収益性: -70.01%
セクタ: Healthcare

プロモーションスケジュール Rani Therapeutics Holdings, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including large molecules, such as peptides, proteins, and antibodies.

さらに詳しく
Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The company was incorporated in 2012 and is headquartered in San Jose, California.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

Выручка 0.000979
EBITDA -0.0261
Число акций ао 0.02551 млрд
P/S 4296.54
P/BV -43.53
EV/EBITDA -165.09
Цена ао 3.18
ISIN US7530181004
Сайт https://www.ranitherapeutics.com
Валюта usd
IPO date 2021-07-30
Sector Health Care
Industry Biotechnology
Валюта отчета usd
1日あたりの価格変動: 0% (2.12)
週ごとの価格変動: -9.79% (2.35)
月ごとの料金変更: -10.55% (2.37)
3ヶ月間の価格変動: -37.09% (3.37)
半年間の価格変動: -70.01% (7.07)
年間の価格変動: +5.47% (2.01)
3年間の価格推移: -86.82% (16.09)
年初からの価格変動: +5.47% (2.01)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0 0
P/BV 3.31 5
P/E 0 0
EV/EBITDA -1.65 0
合計: 3.13

効率

名前 意味 学年
ROA, % -58.65 0
ROE, % -264.03 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.4611 10
合計: 7.8

成長の衝動

名前 意味 学年
収益性 Revenue, % 175.79 10
収益性 Ebitda, % 150.1 10
収益性 EPS, % -6.2 0
合計: 6.6
さらに詳しく

機関 音量 共有, %
Vanguard Group Inc 668347 2.57
Nan Fung Group Holdings Limited 493584 1.9
United Services Automobile Association 481300 1.85
Alphabet Inc. 448492 1.72
Bank of America Corporation 114259 0.44
Geode Capital Management, LLC 113629 0.44
Blackrock Inc. 63583 0.24
Lasry, Marc 62887 0.24
Alpha Square Group S, LLC 58946 0.23
King Luther Capital Management 56129 0.22

ETF 共有, % 年間の利益率, % 配当金, %
Dimensional International Core Equity 2 ETF 0.00033 17.713295799047 3.69996
Dimensional International Small Cap ETF 0.00065 18.692449355433 3.34747
Dimensional International Small Cap Value ETF 0.00059 18.789944610141 4.55441



スーパーバイザー 役職 支払い 生年
Mr. Mir A. Imran Executive Chairman 80k 1956 (68 年)
Mr. Talat Imran CEO & Director 450k 1982 (42 年)
Mr. Svai S. Sanford Chief Financial Officer 416k 1970 (54 年)
Dr. Mir Hashim Chief Scientific Officer 416k 1960 (64 年)
Mr. Eric Groen General Counsel N/A 1971 (53 年)
Ms. Bella Vazquez Vice President of Human Resources N/A
Ms. Kate McKinley M.B.A. Chief Business Officer N/A 1977 (47 年)
Ms. Arvinder Dhalla Vice President of Clinical Development N/A

住所: United States, San Jose. CA, 2051 Ringwood Avenue - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.ranitherapeutics.com